We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Featured News

 

Latest News

Prevalence of Coronavirus Antibodies Declining in England
News   Oct 27, 2020

Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

READ MORE

Mapping the Immune Landscape in Pancreatic Cancer To Guide Immunotherapy
News   Oct 27, 2020

A new study led by the University of Michigan Rogel Cancer Center combined single-cell RNA sequencing with two other investigative techniques to create a network of interactions that suppress the body's immune response in and around pancreatic tumors.

READ MORE

Adaptate Biotherapeutics Appoints Stewart Kay as Chief Business Officer
News   Oct 26, 2020

Adaptate Biotherapeutics (Adaptate) today announced the appointment of Stewart Kay as Chief Business Officer (CBO).

READ MORE

Plant Compound Improves Cognition and Memory in Model of Down Syndrome
News   Oct 26, 2020

The plant compound apigenin improved the cognitive and memory deficits usually seen in a mouse model of Down syndrome, according to a study by researchers at the National Institutes of Health and other institutions.

READ MORE

Ancient DNA Elements Can Activate a Powerful Immune Response to Cancer Cells
News   Oct 23, 2020

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

READ MORE

FDA Approves Remdesivir for COVID-19
News   Oct 23, 2020

The US Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients (≥ 12 years of age and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

READ MORE

Experts Respond to Reported Death of COVID-19 Vaccine Trial Participant
News   Oct 22, 2020

News has emerged from Brazil that a participant of the Phase III clinical trial investigating the COVID-19 vaccine, ChAdOX1, has died.

READ MORE

Major Step Toward Angelman Syndrome Gene Therapy
News   Oct 22, 2020

Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe neurodevelopmental disorder with no cure and limited treatments. Now, for the first time, scientists at the UNC School of Medicine show that gene editing and gene therapy techniques can be used to restore UBE3A in human neuron cultures and treat deficits in an animal model of Angelman syndrome.

READ MORE

Potential Global Hesitancy To Accept a COVID-19 Vaccine
News   Oct 21, 2020

A research team from the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), the Barcelona Institute for Global Health (ISGlobal), the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine (LSHTM), and Georgetown University Law School announced today that Nature Medicine has published their research revealing potential global hesitancy to accept a COVID-19 vaccine.

READ MORE

A Next-Generation Anti-Amyloid Vaccine for Alzheimer’s Disease?
News   Oct 20, 2020

A team led by Chuanhai Cao, PhD, of the University of South Florida Health (USF Health), has focused on overcoming, in those with impaired immunity, excess inflammation and other complications that interfere with development of a therapeutic Alzheimer’s vaccine.

READ MORE

 
Advertisement